RMD Open
ISSN: 2056-5933
Publisher: BMJ Publishing Group
Publications (35)
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination (2022)
Fagni F, Schmidt K, Bohr D, Valor-Mendez L, Tascilar K, Manger K, Manger B, et al.
Journal article, Letter
CT-like images in MRI improve specificity of erosion detection in patients with hand arthritis: A diagnostic accuracy study with CT as standard of reference (2022)
Ulas ST, Ziegeler K, Richter ST, Ohrndorf S, Poddubnyy D, Makowski MR, Diekhoff T
Journal article
Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases. (2022)
Marques A, Bosch P, De Thurah A, Meissner Y, Falzon L, Mukhtyar C, Bijlsma JWJ, et al.
Journal article, Review article
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis (2021)
Pournara E, Kormaksson M, Nash P, Ritchlin CT, Kirkham BW, Ligozio G, Pricop L, et al.
Journal article
CT-like images of the sacroiliac joint generated from MRI using susceptibility-weighted imaging (SWI) in patients with axial spondyloarthritis (2021)
Deppe D, Hermann KG, Proft F, Poddubnyy D, Radny F, Protopopov M, Makowski MR, Diekhoff T
Journal article
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey (2021)
Kernder A, Morf H, Klemm P, Vossen D, Haase I, Mucke J, Meyer M, et al.
Journal article
Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment (2020)
Valor-Méndez L, Hagen M, Kleyer A, Manger B, Schett G
Journal article
Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy (2018)
Leipe J, Christ LA, Arnoldi AP, Mille E, Berger F, Heppt M, Goldscheider I, et al.
Journal article
Secukinumab in the treatment of psoriatic arthritis: Efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial (2018)
Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al.
Journal article
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies (2018)
Gladman DD, Kavanaugh A, Gómez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al.
Journal article